Drawing for UBIK

USPTO serial 79257037

UBIK

Reviewed by CopyMark Law Group

Reg. 6035887Status 700Renewal
Filing date
Status date
Registration date
Apr 21, 2020
Examiner
MESSICK, TABITHA LEE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with UBIK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi, Esq.

Christina M. Licursi, Esq. Wolf Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for developing, running and communicating with software on data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; laboratory equipment, namely, micro-array chips; electronic sensing apparatus for analysing chemical, biochemical, biological, bacteriological and microbiological test samples for scientific testing services; laboratory and scientific apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular test samples and the measurement of ions; laboratory and scientific portable apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular test samples and the measurement of ions; scientific apparatus and instruments for use in DNA, RNA, protein and polynucleic acid sequencing; scientific apparatus for the analysis of polynucleic acid sequences; scientific apparatus and instruments for the analysis of nucleic and polynucleic acids; scientific apparatus and instruments for the analysis of proteins; scientific apparatus and instruments for analysis of genetic information, genomic information and proteomic information; apparatus and instruments for use in laboratory analysis, namely, empty cartridges for test samples in the nature of cartridges for use with concentrates and solutions in solid or liquid form samples for scientific or research testing use; downloadable computer programs, computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; electrowetting-on-dielectric (EWOD) devices for the display of scientific data; scientific apparatus and instruments for automating the extraction and preparation of test samples; scientific apparatus, devices and instruments for synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; data processing apparatus, devices and instruments for the analysis and recordal of scientific data; scientific apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; portable scientific apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; portable computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; computer peripheral devices; electronic display interfaces for the display of information obtained from scientific equipment; silicon chips; DNA chips; biosensor chips for scientific research and scientific testing use; cartridges namely, cartridges for test samples and cartridges for use with concentrates and solutions in solid or liquid form for use in biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis; batteries; rechargeable batteries; chargers for batteries; power packs namely, battery packs; computer docking stations; testing apparatus incorporating chemical or biological reagents for medical purposes, namely, apparatus for testing gas, liquids and solids; reaction units containing chemical or biological reagents being laboratory equipment other than for medical use; scientific apparatus, namely, nanopore sensing devices; none of the aforesaid relating to entertainment, video games and interactive applications for entertainment purposes; none of the foregoing for clearing and settling exchange traded derivatives or smart card issuance and management, nor relating to quality monitoring and assessment of services, customer services, business processes and employee skills and performanceACTIVE
010Medical and veterinary testing and diagnostic apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; electrowetting-on-dielectric (EWOD) devices for medical and veterinary purposes; automated medical apparatus and instruments for the extraction and preparation of test samples for medical and veterinary purposes; portable medical and veterinary testing and diagnostic apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; liquid biopsy instruments; blood testing apparatus; diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; cartridges for test samples and cartridges for use with concentrates and solutions in solid or liquid form for medical use, detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; diagnostic apparatus and instruments in the nature of reaction units containing chemical reagents, namely, reaction systems for medical testing purposes, not for research purposes; medical apparatus, namely, nanopore sensing devices for medical purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 21, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 4, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED
Sep 26, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 5, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB
Aug 26, 2020FIMPFINAL DISPOSITION PROCESSED
Jul 21, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 21, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 2, 2020ATRVATTORNEY REVIEW COMPLETED
Feb 24, 2020LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW
Feb 4, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 4, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 31, 2020GPNXNOTIFICATION PROCESSED BY IB
Jan 15, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 15, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 15, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 30, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 30, 2019XAECEXAMINER'S AMENDMENT ENTERED
Dec 30, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 30, 2019GNEAEXAMINERS AMENDMENT E-MAILED
Dec 30, 2019CNEAEXAMINERS AMENDMENT -WRITTEN
Dec 5, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 5, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2019ALIEASSIGNED TO LIE
Dec 2, 2019ALIEASSIGNED TO LIE
Dec 2, 2019ALIEASSIGNED TO LIE
Nov 22, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 25, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED
Aug 9, 2019LIMGLIMITATION OF GOODS RECEIVED FROM IB
Jun 22, 2019RFNTREFUSAL PROCESSED BY IB
May 31, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 31, 2019RFRRREFUSAL PROCESSED BY MPU
May 7, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 6, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 30, 2019MAFRAPPLICATION FILING RECEIPT MAILED
Apr 26, 2019DOCKASSIGNED TO EXAMINER
Apr 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 25, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance